[ad_1] The disappointing results come weeks after a similar treatment developed by two competitors delivered promising data, infusing fresh hope into a field that has been marked by a string of failures. [ad_2] Source link Source link
Read MoreTag: specialized drugs
[ad_1] The veteran pharmaceutical executive takes charge of after the failed launch of Biogen’s once-promising Alzheimer’s disease drug Aduhelm. [ad_2] Source link Source link
Read More[ad_1] The company has applied for FDA approval of Symplicity Spyral, an experimental device used to perform a minimally invasive treatment procedure. [ad_2] Source link Source link
Read More[ad_1] The pharmaceutical company says its sales could be as much as $3 billion lower this year than initially expected. [ad_2] Source link Source link
Read More[ad_1] Business Drugstore chain agrees to make payments over 10 years to states, cities and tribes that sued over opioid abuse [ad_2] Source link Source link
Read More[ad_1] Health Pfizer says results are sufficient to seek approval for the shot, which could be the first deployed against the common respiratory virus [ad_2] Source link Source link
Read More[ad_1] Rival drugmakers are seeking to upend Pfizer Inc.’s dominance of the $7 billion worldwide market for pneumonia vaccines, launching what is shaping up to be one of the industry’s fiercest battles. Merck & Co. has already introduced a new competitor to Pfizer’s Prevnar vaccine franchise, while GSK PLC and Vaxcyte Inc. are among companies […]
Read More